Frequently asked questions following text message -part 2

Some patients may have received the following message from us.

You are taking an SGLT2 inhibitor

In rare cases, SGLT2 Inhibitors can cause complications, including diabetic ketoacidosis + Fournier’s gangrene. Please seek medical advice immediately if you have any symptoms-

Rapid weight loss

Feeling sick, or stomach pain

Fast, deep breathing

Sweet or metal taste in the mouth

Different odour to your breath, urine or sweat

Severe pain, redness, swelling in the genital area, accompanied by fever or feeling unwell

The Birchwood and Sollershott Surgeries

 

What medication does this apply to?

A group of medicines called SGLT2 inhibitors. These are dapagliflozin, empagliflozin and Canagliflozin. All medicines also have brand names assigned by the manufacturer so you may know your medicine by an alternative name.

 

Why has this only just been brought up?

We regularly review guidelines and carry out audits of our services. Sometimes these activities highlight areas where we can improve patient care, or need to change our approach, this is one such scenario.

Should I continue to take this medication given the side effects listed? 

Yes, we would advise to, as the medication has many benefits and was prescribed for you for good reason. The possible side effects you have been alerted to are very rare, but it is important that you are aware of what symptoms to look out for, so that you can report any concerns to us in a timely fashion.

How urgently should I seek medical attention if I experience these side effects?

As mentioned in the original information shared, these side effects are rare, and the majority of patients will not be affected. However, if you do develop any of the symptoms outlined, please contact the surgery or NHS111 for advice as soon as possible

 

We hope these frequently asked questions help you. Should you wish to discuss further please contact us to book the next routine appointment with a clinician.

Date published: 26th February, 2025
Date last updated: 26th February, 2025